share print

Patient & Consumer

You are at the heart of everything we do

As an innovative consumer healthcare company, we strive to develop and market accessible, added value self-care solutions aimed at empowering and improving the lives of people throughout the world. It has been our dream from the outset to provide our patients and consumers with the best treatments possible and to champion access to medicines across the globe. We aim to provide you with the care and support you need.

Further useful information for you as a patient can be found on the following HRA Pharma pages :
HRA Pharma clinical trials  
Our innovation model 
• Our products : Women's health, endocrinology

We are here for you

Caring for patients and consumers is extremely important to us. We achieve this through close collaboration and open communication with our stakeholders.
If you have a particular question or would like information concerning one of our products, please contact us.  

Women’s health products*

*Please be aware that the availability of treatments, use and brand names may differ from country to country. We advise you to consult your doctor or pharmacist for further advice and to always read instructions carefully before using a product.

Emergency contraception  
Emergency contraception aims to prevent a pregnancy after unprotected sex or contraceptive failure. It should be taken as soon as possible after unprotected sex.

Contraception  
Regular contraception is a planned use of various devices, drugs or surgical procedures to prevent pregnancy and/or plan the timing of a pregnancy.

Intimate health  
HRA Pharma’s intimate health products are designed to treat women who suffer from vaginitis, vaginal injury or vaginal dryness.

Uterine fibroids  
Uterine fibroids are solid tumors of the female genital tract in women of reproductive age.

About 20 percent to 40 percent* of women develop fibroids during their fertile years. Heavy menstrual bleeding (HMB), pelvic pressure and pain and reproductive dysfunction are common symptoms** that impair women's health and quality of life.


*Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 2004;104:393–406.
**Stewart EA. Uterine fibroids. Lancet 2001;357:293–8. Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate? Hum Reprod 2002;17:1424-30.


HRA Pharma endocrinology products*

*Please be aware that the availability of treatments, use and brand names may differ from country to country. We advise you to consult your doctor for further advice and to always read instructions carefully before using a product.

Our research and partnerships are far reaching as we strive to continuously push the boundaries of successful treatments in endocrinology.


Adrenal cancer / Cushing's syndrome

Anyone can get Cushing's syndrome, although it tends to affect adults aged 20-50 years.
Women are three times more likely to develop the syndrome than men*.
*Source : http://www.orpha.net/consor/cgi-bin/index.php



HRA Pharma at your service with LYSOSAFE® 

The HRA Pharma LYSOSAFE® Service is free of charge to all patients. The aim is to provide assistance to healthcare professionals with the use of a medicine indicated for the treatment of Cushing’s syndrome – and to optimize the safety and efficacy of treatment.

closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?